We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-1.55%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$41.7B
AUM Growth
+$2.19B
Cap. Flow
+$590M
Cap. Flow %
1.42%
Top 10 Hldgs %
9.51%
Holding
3,328
New
131
Increased
1,345
Reduced
1,491
Closed
336
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSG
2076
DELISTED
CHAMBERS STR PPTYS COM
CSG
$1.26M ﹤0.01%
167,412
+67,362
+67% +$528K
XOMA
2077
DELISTED
Xoma
XOMA
$1.25M ﹤0.01%
14,895
-211
-1% -$18K
TTMI icon
2078
TTM Technologies
TTMI
$14.7B
$1.25M ﹤0.01%
183,670
-4,058
-2% -$30.7K
ENLK
2079
DELISTED
EnLink Midstream Partners, LP
ENLK
$1.25M ﹤0.01%
41,075
-3,981
-9% -$122K
NXC
2080
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
$1.25M ﹤0.01%
81,138
+13,086
+19% +$200K
CAMP
2081
DELISTED
CalAmp Corp.
CAMP
$1.25M ﹤0.01%
3,081
-403
-12% -$171K
MRCY icon
2082
Mercury Systems
MRCY
$6.41B
$1.25M ﹤0.01%
113,385
-12,281
-10% -$138K
NUW icon
2083
Nuveen AMT-Free Municipal Value Fund
NUW
$251M
$1.25M ﹤0.01%
75,741
-2,385
-3% -$38.9K
BCO icon
2084
Brink's
BCO
$4.67B
$1.25M ﹤0.01%
51,806
-4,762
-8% -$128K
NXQ
2085
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
$1.24M ﹤0.01%
94,053
-3,199
-3% -$42.7K
ASEI
2086
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
$1.24M ﹤0.01%
22,421
+2,199
+11% +$135K
NEWP
2087
DELISTED
NEWPORT CORP
NEWP
$1.24M ﹤0.01%
69,998
-11,940
-15% -$216K
ARMH
2088
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$1.24M ﹤0.01%
28,355
+11,460
+68% +$520K
VAL
2089
DELISTED
Valspar
VAL
$1.24M ﹤0.01%
15,683
-17,587
-53% -$1.38M
OABC
2090
DELISTED
OMNIAMERICAN BANCORP INC COM STK (TX)
OABC
$1.24M ﹤0.01%
47,524
-4,306
-8% -$108K
PNFP icon
2091
Pinnacle Financial Partners Inc
PNFP
$16.1B
$1.23M ﹤0.01%
34,185
-3,674
-10% -$135K
ESL
2092
DELISTED
Esterline Technologies
ESL
$1.23M ﹤0.01%
11,077
-804
-7% -$91.5K
GNC
2093
DELISTED
GNC Holdings, Inc.
GNC
$1.23M ﹤0.01%
31,783
-62,954
-66% -$2.29M
CBK
2094
DELISTED
Christopher & Banks Corporation
CBK
$1.23M ﹤0.01%
124,466
-176,908
-59% -$1.7M
PCK
2095
DELISTED
Pimco California Municipal Income Fund II
PCK
$1.23M ﹤0.01%
133,325
+82,981
+165% +$787K
ABMD
2096
DELISTED
Abiomed Inc
ABMD
$1.23M ﹤0.01%
49,517
-5,323
-10% -$135K
FOR icon
2097
Forestar Group
FOR
$1.52B
$1.23M ﹤0.01%
69,358
-7,478
-10% -$143K
PBY
2098
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
$1.23M ﹤0.01%
137,881
-3,028
-2% -$32.5K
SEIC icon
2099
SEI Investments
SEIC
$12.6B
$1.23M ﹤0.01%
33,906
-2,795
-8% -$99.6K
ASML icon
2100
ASML
ASML
$667B
$1.22M ﹤0.01%
12,351
+4,400
+55% +$414K

Similar funds

Guggenheim Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Guggenheim Capital held 3,328 positions worth $41.7B, up 5.5% from $39.5B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Guggenheim Capital's Q3 2014 filing shows 131 new, 1,345 increased, 1,491 reduced and 336 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M. The largest sale was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, an estimated $98.4M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Guggenheim Capital's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M.
  • Guggenheim Capital added most to CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF in Q3 2014, an estimated $96.3M increase.
  • Guggenheim Capital's biggest Q3 2014 reduction was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, cutting an estimated $98.4M.
  • Guggenheim Capital fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $40.1M.
  • Guggenheim Capital's ten largest holdings make up 9.5% of its $41.7B portfolio in Q3 2014.
  • Guggenheim Capital opened 131 new positions and closed 336 in Q3 2014.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $41.7B.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.